QLIDA Diagnostics
QLIDA develops next-generation biomarker diagnostic tests.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed QLIDA Diagnostics Information
Geographic Data
Address:
City: Philadelphia
State: Pennsylvania
Zip:
Country: United States
Financial Info
Stage:
non equity assistance
Raised Last:
$0
Raised Total:$0
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
QLIDA develops next-generation biomarker diagnostic tests. The company’s proprietary portable, hand-held platform can be used for diagnosis of life-threatening diseases such as cancer and cardiovascular disease, through the use of a nanotechnology-based protein detection. QLIDA has been collaborating with Drexel University to develop its proprietary test, Quantum-dot Linked Immuno-Detection Assay (QLIDA), to create a quantitative biomarker detection platform, enabling early detection of proteins associated with disease. The company is currently developing an ultrasensitive test for cardiovascular disease to be used in point of care testing.
Contact Phone:
Contact Email:
| Announced Date | Company | Transaction | Money Raised |
|---|
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
